Why are the findings of cost-effectiveness analyses of biologic treatment for rheumatoid arthritis so different?
May 1, 2013, 00:00
10.1016/j.jval.2013.03.112
https://www.valueinhealthjournal.com/article/S1098-3015(13)00183-6/fulltext
Title :
Why are the findings of cost-effectiveness analyses of biologic treatment for rheumatoid arthritis so different?
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)00183-6&doi=10.1016/j.jval.2013.03.112
First page :
A19
Section Title :
Research on Methods Studies
Open access? :
No
Section Order :
511